ISPE International Board of Directors 2008-2009 Election

The time period for voting is now over. Thank you for participating!

Your current Board of Directors felt that it would be helpful to explain how the candidates were selected. The following bullet points provide a guide to the steps leading up to the election:

• The global ISPE leadership in Affiliates and Chapters, together with the International Board of Directors and all Committee, Council, Task Team, and Community of Practice leaders were requested to provide the names of potential candidates and their sponsors to the ISPE Nominating Committee. Candidates were proposed on the basis of the contributions they have made to the Society at the local or international level.
  
  
• The Nominating Committee proposed a list of potential candidates for the vacancies on the Executive Council and the International Board of Directors to the Board for their approval. Approximately twice as many candidates as there are vacancies were proposed. The Board voted on that list in June.
  
  
• Approved candidates were asked to confirm their willingness to stand and that they have the support of their employer, and to supply a statement of their intentions.
  
  
• Following the receipt of this information, the balloting process was arranged using an independent outside body, Intelliscan, Inc.

Directors in Place

The following Directors were elected in 2007 to serve a two-year term.

Nuala Calnan
Principal Consultant
PM Group

Charlotte Enghave, PhD
Senior Consultant
NNE Pharmaplan

Nigel Frost
Managing Director
Thermal Transfer Ltd.

Damian J. Greene
Director/Team Leader
Pfizer Inc.

David E. Petko, PE
Senior Director
Auxilium Pharmaceuticals, Inc.

Stephanie A. Wilkins, PE
President
PharmaConsult US Inc.

Past Chairman

The Past Chairman automatically serves one additional year on the Board.

Bruce S. Davis
Global Capital Director
AstraZeneca